GPFA
NNVC icon

Game Plan Financial Advisors’s NanoViricides NNVC Stock Holding History

Game Plan Financial Advisors’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-450
Closed -$459 – 446
2023
Q4 		$459 Buy
+450
New +$520 ﹤0.01% 393

Other funds holding NNVC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Compagnie Lombard Odier SCmA
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bridgeway Capital Management
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Game Plan Financial Advisors's NNVC Position: Q1 2024 in Review

Game Plan Financial Advisors sold out of NanoViricides (NNVC) in Q1 2024, closing a stake of 450 shares — an estimated $459 sold.

Game Plan Financial Advisors first reported a position in NNVC in Q4 2023 and held it in 1 quarter. The position peaked at $459 in Q4 2023. 29 funds tracked by Wall St. Rank hold NNVC as of Q1 2024.

  • Game Plan Financial Advisors reported no remaining NanoViricides position as of Q1 2024 after selling out during the quarter.
  • Game Plan Financial Advisors sold 450 NanoViricides shares in Q1 2024, an estimated $459.
  • Game Plan Financial Advisors first reported a position in NanoViricides in Q4 2023 and held it in 1 quarter.
  • Game Plan Financial Advisors's NanoViricides position peaked at $459 in Q4 2023.
  • 29 funds tracked by Wall St. Rank held NanoViricides as of Q1 2024.

Based on Game Plan Financial Advisors's 13F filing for Q1 2024, filed 12 Apr 2024.